← Open Payments lookup

ASHLEY RAZOR: Open Payments

NPI 1538875026 · NEW CASTLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$675 in 37 payments from 16 companies in 2025. Trend: 2023 $283 · 2024 $870 · 2025 $675

Food & beverage: $675
CompanyPaymentsAmount
ABBVIE INC.10$138
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$75
Novo Nordisk Inc3$72
Otsuka America Pharmaceutical, Inc.2$56
Neurocrine BioSciences, Inc.3$50
Axsome Therapeutics, Inc.3$48
Lundbeck LLC3$46
Alkermes, Inc.2$40
PFIZER INC.1$26
Astellas Pharma US Inc1$25

Products named: VRAYLAR, REXULTI, CAPLYTA, Ozempic, INGREZZA, Auvelity, ARISTADA, QULIPTA.

Industry payments across IN — which companies pay providers there.